NCT03819439

Brief Summary

Analyze, describe, and understand how the human gut microbiome (i.e. bacteriome and mycobiome) and Autism Spectrum Disorder (ASD) are related.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2019

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 28, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

January 30, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 23, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 23, 2019

Completed
Last Updated

July 30, 2019

Status Verified

July 1, 2019

Enrollment Period

6 months

First QC Date

January 15, 2019

Last Update Submit

July 26, 2019

Conditions

Keywords

autismmicrobiomemycobiomebacteriafungi

Outcome Measures

Primary Outcomes (1)

  • Characterize the microbiome [bacteria and fungal community]

    Identifying relative abundance of individual bacterial and fungal members.

    10 years

Interventions

The questionnaire will be administered to collect demographic data (i.e. sex, age, race, and ethnicity) of the volunteers. Additionally, it will ask for the volunteers to identify whether or not they have autism spectrum disorder and what other medical conditions they have and what medications (e.g. prescribed, over the counter, herbal; etc.) that they take.

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Volunteers will or will not have a diagnosis of Autism Spectrum Disorder (ASD). Volunteers will be both local and national. There will be no limit to the number of volunteers who participate; however, we anticipate being able to enroll at least 50 volunteers within the first year.

You may qualify if:

  • Volunteers \> 2 years of age
  • Able to list all medical conditions and medications when applicable.
  • Have already donated a stool sample to BIOHM™.

You may not qualify if:

  • Volunteers \< 2 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospitals Cleveland Medical Center

Cleveland, Ohio, 44106, United States

Location

Biospecimen

Retention: NONE RETAINED

stool samples

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic Disorder

Interventions

Microbiota

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Microbiological PhenomenaBiotaBiodiversityEcosystemEnvironmentEcological and Environmental PhenomenaBiological PhenomenaEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of Medical Mycology

Study Record Dates

First Submitted

January 15, 2019

First Posted

January 28, 2019

Study Start

January 30, 2019

Primary Completion

July 23, 2019

Study Completion

July 23, 2019

Last Updated

July 30, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations